- Lifemd (Nasdaq:Lfmd) It is planned to publish the results of earnings at Q4 on Monday, March 10, after the market closure.
Consensus EPS estimate is $ 0.14 (-6.7% y/y) and the consensus revenue assessment is $ 57.43 million (+28.0% y/y). In the last 2 years, LFMD has won the EPS assessment 100% of the time and won the estimates of 75% of the time.
